Venus Medtech (Hangzhou) Inc.

SZSC:2500 Stock Report

Market Cap: HK$2.5b

Venus Medtech (Hangzhou) Past Earnings Performance

Past criteria checks 0/6

Venus Medtech (Hangzhou)'s earnings have been declining at an average annual rate of -42.6%, while the Medical Equipment industry saw earnings growing at 13.7% annually. Revenues have been growing at an average rate of 16.9% per year.

Key information

-42.6%

Earnings growth rate

-34.9%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate16.9%
Return on equity-37.6%
Net Margin-267.2%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Venus Medtech (Hangzhou) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSC:2500 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23452-1,208500602
31 Mar 23429-1,133468565
31 Dec 22406-1,058437527
30 Sep 22397-759411451
30 Jun 22387-461382374
31 Mar 22401-417364316
31 Dec 21416-374345258
30 Sep 21415-313320231
30 Jun 21413-252295204
31 Mar 21345-217267186
31 Dec 20276-182239167
30 Sep 20252-210247165
30 Jun 20228-238256163
31 Mar 20231-310289182
31 Dec 19233-381322201
31 Dec 18115-300291105
31 Dec 1718-15756117

Quality Earnings: 2500 is currently unprofitable.

Growing Profit Margin: 2500 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2500 is unprofitable, and losses have increased over the past 5 years at a rate of 42.6% per year.

Accelerating Growth: Unable to compare 2500's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2500 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16%).


Return on Equity

High ROE: 2500 has a negative Return on Equity (-37.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies